MicroRNA-21 Modulates Chemosensitivity of Breast Cancer Cells to Doxorubicin by Targeting PTEN

Archives of Medical Research

Volumn 42, Issue 4, 2011, Pages 281-290

  Wang, Zhao Xia ^a   Lu, Bin Bin ^a   Wang, He ^a   Cheng, Zhi Xiang ^a   Yin, Yong Mei ^b  

^a THE SECOND AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Breast cancer; Chemosensitivity; Doxorubicin; MicroRNA 21; PTEN

Indexed keywords

CASPASE 3; DOXORUBICIN; LUCIFERASE; MICRORNA 21; PROTEIN INHIBITOR; SMALL INTERFERING RNA; TETRAZOLIUM; TUMOR SUPPRESSOR PROTEIN;

APOPTOSIS; ARTICLE; ASSAY; BREAST CANCER; CANCER CELL CULTURE; CELL STRAIN MCF 7; CHEMOSENSITIVITY; DOWN REGULATION; DRUG SENSITIVITY; ENZYME ACTIVITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IC 50; NICK END LABELING; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE; UPREGULATION; WESTERN BLOTTING;

ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; BREAST NEOPLASMS; CASPASE 3; CELL LINE, TUMOR; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INHIBITORY CONCENTRATION 50; MICRORNAS; PTEN PHOSPHOHYDROLASE; RNA, SMALL INTERFERING;

EID: 79961088478     PISSN: 01884409     EISSN: 18735487     Source Type: Journal    
DOI: 10.1016/j.arcmed.2011.06.008     Document Type: Article

References (27)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2009. CA Cancer J Clin 2009, 59:225-249.
2. Barrett S.V. Breast cancer. J R Coll Physicians Edinb 2010, 40:335-338.
3. Wahid F., Shehzad A., Khan T., et al. MicroRNAs: synthesis, mechanism, function, and recent clinical trials. Biochim Biophys Acta 2010, 1803:1231-1243.
4. Di Leva G., Croce C.M. Roles of small RNAs in tumor formation. Trends Mol Med 2010, 16:257-267.
5. Bandres E., Agirre X., Ramirez N., et al. MicroRNAs as cancer players: potential clinical and biological effects. DNA Cell Biol 2007, 26:273-282.
6. Subramanian S., Steer C.J. MicroRNAs as gatekeepers of apoptosis. J Cell Physiol 2010, 223:289-298.
7. Dykxhoorn D.M. MicroRNAs and metastasis: little RNAs go a long way. Cancer Res 2010, 70:6401-6406.
8. Asaga S., Kuo C., Nguyen T., et al. Direct serum assay for microRNA-21 concentrations in early and advanced breast cancer. Clin Chem 2011, 57:84-91.
9. Huang G.L., Zhang X.H., Guo G.L., et al. Clinical significance of miR-21 expression in breast cancer: SYBR-Green I-based real-time RT-PCR study of invasive ductal carcinoma. Oncol Rep 2009, 21:673-679.
10. Song B., Wang C., Liu J., et al. MicroRNA-21 regulates breast cancer invasion partly by targeting tissue inhibitor of metalloproteinase 3 expression. J Exp Clin Cancer Res 2010, 29:29.
11. Zhu S., Wu H., Wu F., et al. MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res 2008, 18:350-359.
12. Farazi T.A., Spitzer J.I., Morozov P., et al. miRNAs in human cancer. J Pathol 2011, 223:102-115.
13. Gao W., Shen H., Liu L., et al. MiR-21 overexpression in human primary squamous cell lung carcinoma is associated with poor patient prognosis. J Cancer Res Clin Oncol 2011, 137:557-566.
14. Li J., Huang H., Sun L., et al. MiR-21 indicates poor prognosis in tongue squamous cell carcinomas as an apoptosis inhibitor. Clin Cancer Res 2009, 15:3998-4008.
15. Li Y., Zhu X., Gu J., et al. Anti-miR-21 oligonucleotide enhances chemosensitivity of leukemic HL60 cells to arabinosylcytosine by inducing apoptosis. Hematology 2010, 15:215-221.
16. Giovannetti E., Funel N., Peters G.J., et al. MicroRNA-21 in pancreatic cancer: correlation with clinical outcome and pharmacologic aspects underlying its role in the modulation of gemcitabine activity. Cancer Res 2010, 70:4528-4538.
17. Shi G.H., Ye D.W., Yao X.D., et al. Involvement of microRNA-21 in mediating chemo-resistance to docetaxel in androgen-independent prostate cancer PC3 cells. Acta Pharmacol Sin 2010, 31:867-873.
18. Shi L., Chen J., Yang J., et al. MiR-21 protected human glioblastoma U87MG cells from chemotherapeutic drug temozolomide induced apoptosis by decreasing Bax/Bcl-2 ratio and caspase-3 activity. Brain Res 2010, 1352:255-264.
19. Tomimaru Y., Eguchi H., Nagano H., et al. MicroRNA-21 induces resistance to the anti-tumour effect of interferon-α/5-fluorouracil in hepatocellular carcinoma cells. Br J Cancer 2010, 103:1617-1626.
20. Gu J., Zhu X., Li Y., et al. miRNA-21 regulates arsenic-induced anti-leukemia activity in myelogenous cell lines. Med Oncol 2011, 28:211-218.
21. Qian B., Katsaros D., Lu L., et al. High miR-21 expression in breast cancer associated with poor disease-free survival in early stage disease and high TGF-beta1. Breast Cancer Res Treat 2009, 117:131-140.
22. Yan L.X., Huang X.F., Shao Q., et al. MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. RNA 2008, 14:2348-2360.
23. Frankel L.B., Christoffersen N.R., Jacobsen A., et al. Programmed cell death 4 (PDCD4) is an important functional target of the microRNAmiR-21 in breast cancer cells. J Biol Chem 2008, 283:1026-1033.
24. Si M.L., Zhu S., Wu H., et al. miR-21-mediated tumor growth. Oncogene 2007, 26:2799-2803.
25. Meng F., Henson R., Wehbe-Janek H., et al. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 2007, 133:647-658.
26. Bai H, Xu R, Cao Z, et al. Involvement of miR-21 in resistance to daunorubicin by regulating PTEN expression in the leukaemia K562 cell line. FEBS Lett 201;585:402-408.
27. Zhang J.G., Wang J.J., Zhao F., et al. MicroRNA-21 (miR-21) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC). Clin Chim Acta 2010, 411:846-852.